| METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE |
208535 |
001 |
ANDA |
METFORMIN HYDROCHLORIDE;SITAGLIPTIN PHOSPHATE |
TABLET;ORAL |
50MG/500MG;50MG/1000MG |
No
|
No
|
2017/07/03
(TA)
|
--
|
ZYDUS PHARMS USA INC |
None (Tentative Approval) |
| METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE |
212338 |
001 |
ANDA |
METFORMIN HYDROCHLORIDE || SITAGLIPTIN |
TABLET:FILM COATED |
50MG |
No
|
No
|
2025/01/07
(TA)
|
--
|
MACLEODS PHARMS LTD |
None (Tentative Approval) |
| METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE |
212338 |
002 |
ANDA |
METFORMIN HYDROCHLORIDE || SITAGLIPTIN |
TABLET;FILM COATED |
500MG |
No
|
No
|
2025/01/07
(TA)
|
--
|
MACLEODS PHARMS LTD |
None (Tentative Approval) |
| METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE |
212338 |
003 |
ANDA |
METFORMIN HYDROCHLORIDE || SITAGLIPTIN |
TABLET;FILM COATED |
1000MG |
No
|
No
|
2025/01/07
(TA)
|
--
|
MACLEODS PHARMS LTD |
None (Tentative Approval) |